Gene therapy specialist MeiraGTx is spinning some of its experimental medicines for the central nervous system into a startup that hopes to develop them further using artificial intelligence.
Aptly named Hologen Neuro AI, the startup is a joint venture between MeiraGTx and Hologen, a healthcare-focused, generative AI firm that taps what’s known as real-world data to better understand the biology of diseases and how to treat them. While…
Article Source
https://www.biopharmadive.com/news/meiragtx-ai-hologen-neuro-gene-therapy-parkinsons-obesity/742452/
